These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10811493)

  • 1. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument.
    Tropé C; Kaern J; Hogberg T; Abeler V; Hagen B; Kristensen G; Onsrud M; Pettersen E; Rosenberg P; Sandvei R; Sundfor K; Vergote I
    Ann Oncol; 2000 Mar; 11(3):281-8. PubMed ID: 10811493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.
    Paulsen T; Kærn J; Tropé C
    Gynecol Oncol; 2011 Jul; 122(1):83-8. PubMed ID: 21435701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.
    Bamias A; Karadimou A; Soupos N; Sotiropoulou M; Zagouri F; Haidopoulos D; Thomakos N; Rodolakis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2011 Oct; 123(1):37-42. PubMed ID: 21764430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
    Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
    Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
    J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer.
    Kristensen GB; Kildal W; Abeler VM; Kaern J; Vergote I; Tropé CG; Danielsen HE
    Ann Oncol; 2003 Oct; 14(10):1494-500. PubMed ID: 14504048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer.
    Colombo N; Guthrie D; Chiari S; Parmar M; Qian W; Swart AM; Torri V; Williams C; Lissoni A; Bonazzi C;
    J Natl Cancer Inst; 2003 Jan; 95(2):125-32. PubMed ID: 12529345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA ploidy in epithelial ovarian cancer--an independent prognostic factor].
    Tropé CG; Abeler V; Baekelandt M; Kaern J
    Tidsskr Nor Laegeforen; 2000 Jan; 120(1):43-9. PubMed ID: 10815478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging.
    Shimada M; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Minagawa Y; Ishihara K; Takeuchi Y; Okada M; Terakawa N
    Int J Gynecol Cancer; 2005; 15(4):601-5. PubMed ID: 16014112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of tumor cell ploidy in advanced ovarian carcinoma].
    Novik VI; Gevorkian VA; Maksimov SIa
    Vopr Onkol; 2006; 52(1):54-8. PubMed ID: 16715704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma.
    Skírnisdóttir I; Lindborg K; Sorbe B
    Oncol Rep; 2007 Nov; 18(5):1249-56. PubMed ID: 17914581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
    Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and prognostic factors in early-stage epithelial ovarian carcinoma treated with taxane-based adjuvant chemotherapy.
    Skírnisdóttir I; Sorbe B
    Int J Gynecol Cancer; 2007; 17(6):1231-7. PubMed ID: 17425681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer.
    van Baal JOAM; Van de Vijver KK; Algera MD; van der Aa MA; Sonke GS; van Driel WJ; Kenter GG; Amant FC; Lok CAR
    Gynecol Oncol; 2019 Jun; 153(3):562-567. PubMed ID: 30948193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.